HLA Typing for Transplant Market : Increasing Number of Transplant Procedures
The demand for transplant diagnostic products is expected to grow mainly due to factors such as the increasing public-private funding for target research activities, the growing burden of infectious diseases, the growing number of transplant procedures, and technological advancements in the field of transplant diagnostics.
The HLA typing for the transplants market is expected to reach USD 968 million by 2025 from USD 656 million in 2019, at a CAGR of 6.7%.
The molecular assay technologies segment accounted for the largest share of the HLA typing for transplants market, by technology, in 2019.
The HLA typing for the transplants market, by technology, is segmented into molecular and non-molecular assay technologies. In 2019, the molecular assay technologies segment accounted for the largest share of the HLA typing for the transplants market. The large share of this segment can be attributed to the benefits offered by molecular assays such as low turnaround time, high procedural efficacy, the study of multiple samples, and real-time sample analysis.
Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=96374742
The independence reference laboratories end-user segment accounted for the largest share of the HLA typing for transplants market in 2019
Based on end-user, the HLA typing for the transplants market is segmented into independent reference laboratories, hospitals & transplant centers, and research laboratories & academic institutes. In 2019, independent reference laboratories accounted for the largest share of the HLA typing for the transplants market.
North America accounted for the largest share of the HLA typing for transplants market in 2019
North America is a well-established market for medical devices. The presence of a highly developed healthcare system, high adoption of innovative transplant diagnostic technologies (includes HLA typing) among medical professionals, the large volume of organ transplantation procedures performed in the region, and technological advancements in the field of transplant diagnostics are the major factors driving the market in North America.
Request for Sample Pages @
https://www.marketsandmarkets.com/requestsampleNew.asp?id=96374742
Key Market Players
Some of the prominent players in market are Thermo Fisher Scientific, Inc. (US), QIAGEN N.V. (Netherlands), Illumina (US), CareDx, Inc. (US), Immucor, Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), Hologic, Inc. (US), Luminex (US), Biofortuna (UK), Takara Bio (Japan), Omixon (Hungary)
Key Questions Addressed by the Report:
- What are the growth opportunities related to the adoption of HLA typing for transplant products across significant regions in the future?
- Emerging countries show immense opportunities for the growth and adoption of HLA typing for transplant instruments, related reagents & consumables, and software. Will this scenario continue in the next five years?
- Where will the advancements in products offered by various companies take the industry in the mid- to long-term?
- What are the newest trends and advancements in the HLA typing for the transplants market?
Media Contact
Company Name: MarketsandMarkets
Contact Person: Mr. Ashish Mehra
Email: Send Email
Phone: 1-888-600-6441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/hla-typing-market-39129877.html
